Restoration Wellness of Idaho LLC

Flu season has barely begun, yet the Inland Northwest has already received a reminder that influenza can become serious. On October 19, 2026, Spokane Regional Health District confirmed the first influenza related death of the season in Spokane County. The individual was in their 80s, had underlying medical conditions, and was one of 13 county residents already hospitalized with influenza complications.[1] Influenza deserves to be taken seriously, but taking influenza seriously should not require reducing the entire discussion of seasonal immune health to one intervention.

Every autumn, the public health conversation tends to narrow rapidly toward influenza vaccination. Vaccination is one tool that can influence adaptive immune recognition and memory, but immunity is considerably more complicated than antibody production. The body is simultaneously responding to viral exposure, nutritional status, glucose regulation, sunlight, sleep, psychological stress, chronic disease, age, respiratory exposures, physical barriers, and the function of several interconnected classes of immune cells. When those variables change together during fall and winter, focusing exclusively on one piece of the immune response can obscure the larger biological picture.

My interest in this subject is not exclusively academic. In 2016, my husband became critically ill approximately eight hours after receiving an influenza vaccine. He developed a fever above 105 degrees, became septic, and nearly died. A temporal association in one person cannot establish the mechanism responsible for his illness or predict how another person will respond, but living through that event permanently changed how I approach informed consent, individual risk, and blanket recommendations that sometimes make remarkably different human bodies sound interchangeable.

Population level evidence is important in public health, but population averages do not erase individual biology. A recommendation can demonstrate benefit across thousands or millions of people while particular individuals still experience very different outcomes, which is precisely why personal history, contraindications, comorbidities, and informed consent remain important. The same principle applies outside vaccination. Two people can encounter the same respiratory virus and have remarkably different experiences because the immune response occurs inside an entire biological environment rather than inside a statistical average.

To understand that environment, we need to stop treating the immune system as one thing. It is a coordinated network of physical barriers, immune cells, lymphatic tissues, signaling molecules, antibodies, inflammatory pathways, and communication systems distributed throughout the body. At its most basic level, immunity is commonly divided into two interacting branches called innate immunity and adaptive immunity.[2] I often describe them as the immediate immune system and the long acting immune system because those terms make the distinction easier to visualize without changing the underlying science.

Innate immunity is already standing guard before a specific infection appears. Skin, mucus, antimicrobial substances, neutrophils, macrophages, dendritic cells, natural killer cells, and other components of innate defense respond rapidly to recognizable signs of damage or infection.[2] Unlike adaptive immune cells, these defenses do not need to identify one exact strain of one exact virus before beginning their work. They recognize broader molecular patterns that signal that something does not belong, which allows the first response to begin within minutes or hours rather than waiting for highly specific immunity to develop.

A useful way to picture innate immunity is as a neighborhood patrol. The patrol does not need the intruders name, biography, and fingerprints before recognizing someone climbing through a bedroom window. Macrophages can engulf microorganisms and cellular debris, neutrophils can rapidly migrate toward infection, dendritic cells help connect innate recognition with adaptive responses, and natural killer cells can recognize and destroy certain infected or abnormal cells. The analogy is simple, but the underlying biology is sophisticated because these cells are constantly receiving, interpreting, and transmitting information.

Inflammation is also part of this immediate defense system, which is why describing all inflammation as harmful creates another biological oversimplification. Acute inflammation helps recruit immune cells, alters local blood flow, coordinates cellular signaling, and creates conditions that help contain infection or repair tissue. Problems arise when inflammatory responses become excessive, chronically activated, poorly regulated, or insufficient for the threat involved. Healthy immunity therefore does not mean producing the largest possible response. It means producing an appropriate response and then resolving it when the job is finished.

Adaptive immunity operates differently because it develops highly specific responses to particular antigens. B lymphocytes can mature into plasma cells that produce antibodies, while T lymphocytes perform several functions including coordinating immune responses and identifying infected cells. Some B and T cells persist after the original immune challenge as memory cells, allowing a more rapid and targeted response if the same antigen is encountered later.[3] This is the immune memory most people have learned about, and it is also the branch of immunity most directly associated with the intended mechanism of vaccination.

If innate immunity is neighborhood patrol, adaptive immunity functions more like a detective division that builds a detailed case file. It identifies highly specific characteristics of the threat, develops a targeted response, and retains information that may become useful during future exposure. These two systems are not competitors because innate immune cells help initiate and shape adaptive responses, while adaptive immunity can influence subsequent innate activity. The immune system works because its parts communicate, which is why antibodies alone cannot serve as a complete measurement of immune resilience.

This distinction becomes particularly interesting when we begin discussing beta glucans. Beta glucans are a family of polysaccharides composed of glucose molecules, but the phrase beta glucan does not describe one identical substance. Beta glucans occur in fungi, yeast, mushrooms, cereal grains, algae, and other biological sources, and their structures can differ considerably in linkage, branching, molecular weight, solubility, and three dimensional configuration. Those differences matter because biological activity depends partly on structure and on which receptors and immune cells interact with that structure.[4]

Much of the classic immune research involves fungal and yeast beta glucans containing beta 1,3 backbones with beta 1,6 branching. These structures can be recognized by pattern recognition receptors such as Dectin 1, which is expressed on innate immune cells including monocytes, macrophages, and dendritic cells.[4] Dectin 1 activation can initiate intracellular signaling that influences phagocytosis, cytokine production, cellular metabolism, and other components of innate immune activity. This is considerably more precise than simply saying beta glucans boost immunity because the biology involves recognition, signaling, regulation, and cellular behavior rather than a generic increase in immune strength.

For an eighth grade picture, imagine that a macrophage carries a collection of biological scanners. Dectin 1 is one of those scanners, and certain beta glucan structures fit the scanner well enough to trigger a signal inside the cell. That signal can change how the cell behaves, how it communicates with neighboring cells, and how it prepares for subsequent challenges. The molecule is not an antibody and it is not teaching the immune system to recognize one particular strain of influenza. It is interacting with a much older pattern recognition system that belongs primarily to innate immunity.

The story becomes even more interesting because researchers no longer describe innate immunity as completely forgetful. A growing field called trained immunity examines how certain exposures can create metabolic and epigenetic changes in innate immune cells or their precursors, influencing how those cells respond to later challenges.[4] Beta glucans are among the most extensively studied triggers of this phenomenon, particularly in experimental research involving monocytes and macrophages. Trained immunity is not the same as adaptive immune memory because it does not depend on the highly specific antigen recognition used by B and T lymphocytes, but it demonstrates that the old division between fast but forgetful innate immunity and slow but remembering adaptive immunity was too simple.

This brings us to an important distinction that changed how I wanted to discuss beta glucans in this article. Young Living Immugummies, a product I am familiar with as a Young Living brand partner, do not use the same yeast or mushroom beta 1,3 and 1,6 glucans that dominate much of the Dectin 1 literature. Young Living identifies the ingredient as an algae sourced 1,3 beta glucan obtained from Euglena gracilis through indoor fermentation.[5] Euglena gracilis produces an insoluble beta 1,3 glucan called paramylon, which is structurally different from the branched fungal beta glucans often used to explain Dectin 1 signaling.

That distinction is exactly why supplement sourcing matters. A bottle can say beta glucan while containing a compound that differs structurally from a beta glucan in another product, and those differences can affect biological behavior. Young Living describes Immugummies as containing algal beta glucans along with elderberry, elderflower, and Lime essential oil, and the company appropriately includes the standard dietary supplement disclaimer that the product is not intended to diagnose, treat, cure, or prevent disease.[5] For educational purposes, I find the algal source particularly interesting because human research exists on Euglena gracilis rather than forcing us to assume that findings from mushroom or yeast glucans automatically apply to every beta glucan source.

One randomized, double blind, placebo controlled trial studied a proprietary Euglena gracilis fermentate containing more than 50 percent beta 1,3 glucan in 34 healthy endurance trained adults over 90 days. Participants receiving the fermentate reported fewer sick days, fewer upper respiratory symptoms, fewer symptom days, and fewer upper respiratory episodes than participants receiving placebo, although the sample was small and the results should not be interpreted as proof that algal beta glucan prevents influenza.[6] Another randomized controlled trial studied 700 milligrams of Euglena gracilis powder daily for eight weeks and reported increased natural killer cell activity in apparently healthy adults.[7] These studies are scientifically interesting because they suggest measurable immune effects in humans while also illustrating why formulation, dose, population, and source need to be considered before making broad claims about beta glucans.

More recent research has continued examining this organism within normal dietary intake. A randomized controlled trial published in 2026 studied 200 healthy Japanese adults receiving Euglena gracilis for eight weeks and evaluated immune function alongside common cold symptoms.[8] Research of this kind does not turn Euglena into a flu treatment, nor should dietary supplements be presented as substitutes for medical care. It does, however, strengthen the case for discussing innate immune nutrition with considerably more sophistication than the familiar phrase take something to boost immunity.

The word regulation is more useful than boost because the immune system does not function best when every pathway is operating at maximum intensity. Excessive immune activation can damage healthy tissue just as inadequate immune activity can leave the body poorly equipped to respond to a threat. Cytokines, inflammatory pathways, phagocytic activity, antibody production, natural killer cell activity, and T cell responses all need timing and proportion. Immune resilience therefore depends on the ability to recognize a threat, mount an appropriate response, communicate effectively between systems, and eventually resolve the response.

That broader concept also changes how we should think about holiday nutrition. October candy moves into Thanksgiving desserts and then into several weeks of Christmas treats, sweetened beverages, irregular meals, and highly processed foods. One cookie does not shut down the immune system, and I do not teach people to fear food, but glucose regulation is relevant to immune function. A review of acute hyperglycemia and innate immunity found effects involving neutrophil activity, phagocytosis, cytokine patterns, complement function, and other early immune defenses.[9]

The relevant question is therefore not whether pumpkin pie causes influenza. The more useful question is what happens when unstable glucose regulation exists alongside inadequate sleep, low physical activity, chronic stress, poor nutrient intake, and increased viral exposure for several months. The immune system lives inside the same metabolic environment as the pancreas, liver, nervous system, and cardiovascular system. Seasonal immune health becomes much easier to understand once we stop pretending those systems occupy separate bodies.

Sunlight changes at the same time, which brings vitamin D into the conversation. Vitamin D participates in immune regulation, but the evidence surrounding supplementation and respiratory infection is a useful reminder that biological plausibility and clinical outcomes are not identical. An updated 2025 systematic review and meta analysis included data from more than 61,000 participants and found that vitamin D supplementation did not produce a statistically significant overall reduction in acute respiratory infections, although the point estimate remained close to findings from earlier analyses.[10] That means vitamin D is biologically relevant without justifying a claim that supplementation acts as a respiratory infection shield.

This is why I prefer measuring and addressing individual nutritional status rather than treating every nutrient as a universal high dose intervention. Deficiency matters, but more is not automatically better. Nutrients participate in systems, and physiological adequacy is different from supplement maximalism. An evidence based holistic approach should be capable of appreciating the importance of nutrition without turning every molecule into a miracle.

Stress is another biological variable that often disappears from flu season conversations even though the nervous, endocrine, and immune systems communicate continuously. A large meta analysis of 293 independent studies involving 18,941 participants found that the immune effects of stress differed according to the duration and character of the stressor. Acute stress could temporarily increase some parameters of natural immunity, while chronic stress was associated with broader suppression or dysregulation of cellular and humoral immune measures.[11] Stress therefore does not simply weaken immunity in one predictable way, but prolonged physiological stress can substantially change immune behavior.

That has practical implications during the holidays because caregiving, financial strain, disrupted sleep, grief, loneliness, social conflict, and packed schedules often intensify during the same months that respiratory virus exposure increases. These experiences are not merely emotional events occurring outside the body. The brain, endocrine system, and immune system exchange signals, and chronic stress can change the physiological environment in which an immune response takes place. A serious conversation about seasonal resilience should therefore include psychological and social stress rather than treating them as optional wellness topics.

Vaccination belongs inside this larger immune discussion, but it should not consume the entire discussion. Influenza vaccination is intended to generate adaptive immune responses against selected influenza antigens, and effectiveness varies according to season, circulating strains, age, study population, and measured outcome. During the 2025 to 2026 season, preliminary CDC estimates among adults showed vaccine effectiveness against outpatient influenza ranging from approximately 22 to 34 percent, while effectiveness against influenza associated hospitalization in the VISION network was approximately 30 percent.[12] Those numbers demonstrate risk reduction, not guaranteed prevention, and understanding that difference is part of informed consent.

Vaccination also cannot correct a nutrient deficiency, restore lost sleep, stabilize blood glucose, resolve chronic stress, provide protein, improve indoor air, or make someone stay home when actively ill. Conversely, eating well, sleeping adequately, and using nutritional support do not guarantee that someone will not develop influenza or experience complications. These are not competing truths. They are different components of a much larger system, and good public health education should be able to discuss all of them without forcing people into simplistic camps.

The first influenza related death of a season understandably receives attention because influenza can be serious. A person died, a family lost someone, and that deserves respect rather than exploitation from either side of a vaccination argument. The better public health question is not simply how to persuade people toward one intervention. It is what influences human resilience to respiratory infection and which of those vulnerabilities can reasonably be addressed.

Once we ask that question, the conversation becomes considerably richer. We begin talking about innate barriers, macrophages, neutrophils, natural killer cells, adaptive memory, nutritional sufficiency, glucose regulation, sunlight, vitamin status, sleep, chronic disease, psychological stress, indoor exposure, respiratory hygiene, and informed medical decisions. We can also discuss beta glucans without pretending that every beta glucan is identical, and we can examine Euglena gracilis without claiming that a promising nutritional ingredient is a treatment for influenza. That is the kind of health education I want more people to receive because it teaches the body instead of merely issuing instructions.

Flu season has more than one villain because the human immune system has more than one moving part. The immediate immune system provides rapid pattern recognition and early defense, while adaptive immunity develops highly specific responses and longer-term memory. Research into trained immunity is revealing that even this basic distinction is more complicated than we once believed, and nutritional compounds such as beta glucans give us a fascinating window into that science. Influenza deserves respect, but so does the complexity of the human body, and understanding that complexity gives people something fear based messaging never can: context.

I am a Young Living Brand Partner and use Immugummies as one example of an algae sourced beta 1,3 glucan product. If you would like help finding Immugummies, understanding the ingredients, or setting up a Young Living account through me, contact me at info@restorationwellnessofidaho.com and reference Young Living member #15152538.